The major clinical syndromes of pneumococcal disease are pneumonia, bacteremia, and meningitis. The immunologic mechanism that allows disease to occur in a carrier is not clearly understood. However, disease most often occurs when a predisposing condition exists, particularly pulmonary disease, and, if it is going to occur at all, shortly after carriage is acquired.
Pneumococcal pneumonia is the most common clinical presentation of pneumococcal disease among adults, although pneumonia without bacteremia or empyema is not considered to be “invasive” disease. The incubation period of pneumococcal pneumonia is short, about 1 to 3 days. Symptoms generally include an abrupt onset of fever and chills or rigors. Typically there is a single rigor, and repeated shaking chills are uncommon. Other common symptoms include pleuritic chest pain, cough productive of mucopurulent, rusty sputum, dyspnea, tachypnea, hypoxia, tachycardia, malaise, and weakness. Nausea, vomiting, and headaches occur less frequently.
As many as 400,000 hospitalizations from pneumococcal pneumonia are estimated to occur annually in the United States. Pneumococci account for about 30% of adult community-acquired pneumonia. Bacteremia occurs in up to 25–30% of patients with pneumococcal pneumonia. The case-fatality rate is 5-7% and may be higher than 50% among elderly persons. Complications of pneumococcal pneumonia include empyema (infection of the pleural space), pericarditis (inflammation of the sac surrounding the heart), and respiratory failure.
About 12,000 cases of pneumococcal bacteremia occur each year. The overall case-fatality rate for bacteremia is about 15% but may be as high as 60% among elderly patients. Patients with asplenia who develop bacteremia may experience a fulminant clinical course.
Bacteremia without a known site of infection is the most common invasive clinical presentation of pneumococcal infection among children 2 years of age and younger, accounting for approximately 40% of invasive disease in this age group. Bacteremic pneumonia accounts for about 30% of invasive pneumococcal disease among children 2 years of age and younger.
Pneumococci cause 13–19% of all cases of bacterial meningitis in the United States. An estimated 3,000 cases of pneumococcal meningitis occur each year. Some patients with pneumococcal meningitis also have pneumonia. The clinical symptoms, cerebrospinal fluid profile, and neurologic complications are similar to other forms of purulent bacterial meningitis. Symptoms may include headache, lethargy, vomiting, irritability, fever, nuchal rigidity, cranial nerve signs, seizures, and coma. The case-fatality rate of pneumococcal meningitis is 10% but may be higher among elderly persons. Neurologic sequelae are common among survivors. Persons with a cochlear implant appear to be at increased risk of pneumococcal meningitis.
With the decline of invasive Hib disease, S. pneumoniae has become the leading cause of bacterial meningitis among children younger than 5 years of age in the United States. Before routine use of pneumococcal conjugate vaccine, children younger than 1 year had the highest rates of pneumococcal meningitis, approximately 10 cases per 100,000 population.
Acute Otitis Media
Pneumococci are a common cause of acute otitis media, and are detected in 28–55% of middle ear aspirates. By age 12 months, more than 60% of children have had at least one episode of acute otitis media. Middle ear infections are the most frequent reasons for pediatric office visits in the United States, resulting in more than 20 million visits annually. Complications of pneumococcal otitis media may include mastoiditis and meningitis.Top of Page
Pink Book’s Chapter on Pneumococcal Disease
Epidemiology and Prevention of Vaccine-Preventable Diseases textbook
- Page last reviewed: June 6, 2013
- Page last updated: June 6, 2013
- Content source: